Novartis will discontinue studies of an experimental lung-cancer cancer drug because of disappointing trial results.
Continue reading Novartis Halts Lung Cancer Drug Study
Novartis Halts Lung Cancer Drug Study originally appeared on DailyFinance on Thu, 11 Nov 2010 08:15:00.
Filed Under: Company News, Health Care, Novartis, Stocks in the News
